David Reddy
Amministratore Delegato presso MMV Medicines for Malaria Venture
Provenienza dei contatti di primo grado di David Reddy
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.
17
| Non-Profit Organization | Miscellaneous Commercial Services | 17 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.
17
| Non-Profit Organization | Biotechnology | 17 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012.
11
| Non-Profit Organization | Advertising/Marketing Services | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Reddy tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer President Chief Executive Officer Corporate Officer/Principal | |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
United States Council for International Business | Director/Board Member Director/Board Member | ||
ROCHE HOLDING AG | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Partnership for New York City, Inc.
The Partnership for New York City, Inc. Miscellaneous Commercial ServicesCommercial Services The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Chairman | |
UCB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Catalyst, Inc.
Catalyst, Inc. Miscellaneous Commercial ServicesCommercial Services Catalyst, Inc. provides research and advisory services. The company was founded in 1962 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Roche Diagnostics AG
Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Medical Specialties | Director of Finance/CFO Chief Executive Officer | |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | President Chief Executive Officer | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Farmaindustria | President Corporate Officer/Principal | ||
Ivcc
Ivcc Miscellaneous Commercial ServicesCommercial Services IVCC is a British company that works to prevent vector-borne diseases and combat insecticide resistance. The private company is based in Liverpool, UK. The company achieves this by directly targeting the vector that transmits the disease. The company's Research & Development Portfolio is dedicated to innovative work that prevents vector-borne diseases and tackles insecticide resistance. IVCC was founded in 2005, and the CEO is Nick Hamon. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Roche Diagnostics Asia Pacific Pte Ltd.
Roche Diagnostics Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Roche Diagnostics Asia Pacific Pte Ltd. operates as a biotechnology company. Its solutions include serum work area solution, hemostasis testing, hematology, urinalysis, molecular diagnostics, blood safety solutions, and digital services. The company was founded in 1998 and is headquartered in Singapore. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | President | |
Escuela Técnica Superior de Ingeniería | College/University | Undergraduate Degree | |
Roche (Brussels) | Director of Finance/CFO | ||
Grupo Corporativo Landon SL
Grupo Corporativo Landon SL Real Estate DevelopmentFinance Grupo Corporativo Landon SL provides real estate development and management services. The company was founded on January 1, 1988 and is headquartered in Madrid, Spain. | Real Estate Development | Director/Board Member | |
Roche Holdings, Inc.
Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chairman | |
Goodgrower SA
Goodgrower SA Financial ConglomeratesFinance Part of Grupo Corporativo Landon SL, Goodgrower SA invests in the healthcare sector. The company is based in Barcelona, Spain. | Financial Conglomerates | Director/Board Member | |
Roche Deutschland Holding GmbH
Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The company was founded in 1997 by Fritz Hoffmann-La Roche. The CEO is Claudia Fleischer. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
University of Innsbruck | College/University | Doctorate Degree | |
European Round Table of Industrialists | Corporate Officer/Principal | ||
WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma AG is a world leader in innovative cancer drugs and has brought many highly effective drugs onto the market. The company is based in Grenzach-Wyhlen, Germany. The German company also focuses on viral infections, metabolic, central nervous system disorders, and inflammatory diseases. Roche Diagnostics, a subsidiary of Roche Pharma, develops diagnostic tests, instruments, and digital solutions to transform healthcare globally. Roche has been committed to improving lives since its founding in 1896 and creates innovative medicines and diagnostic tests that help millions of patients worldwide. | Medical Distributors | Chairman | |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Chief Executive Officer | |
STALLERGENES | Pharmaceuticals: Major | Director/Board Member | |
Ares Partners CIV LP
Ares Partners CIV LP Financial ConglomeratesFinance Ares Partners CIV LP provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
Merck Serono Europe Ltd. | Chief Executive Officer | ||
The European Association for Bioindustries | Corporate Officer/Principal | ||
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member | |
Esaote SpA
Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Medical Specialties | Director/Board Member | |
International School of Modern Languages | College/University | Undergraduate Degree | |
Fondation Suisse de Recherche sur les Maladies Musculaires | Corporate Officer/Principal | ||
Campus Holding SA
Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Investor | |
GlaxoSmithKline Sante Grand Public SAS
GlaxoSmithKline Sante Grand Public SAS Medical DistributorsDistribution Services Glaxosmithkline Sante Grand Public wholesales pharmaceutical products. The company is headquartered in Rueil-malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
INSEAD | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Regno Unito | 7 |
Svizzera | 7 |
Belgio | 6 |
Germania | 6 |
Settori
Health Technology | 24 |
Finance | 8 |
Commercial Services | 6 |
Consumer Services | 5 |
Distribution Services | 3 |
Posizioni
Director/Board Member | 226 |
Corporate Officer/Principal | 91 |
Chairman | 91 |
Chief Executive Officer | 62 |
Independent Dir/Board Member | 39 |
Contatti più connessi
Insiders | |
---|---|
Tapan Durgadas Ray | 61 |
Dieter Weinand | 32 |
Ian Read | 29 |
Ulf Arne Wiinberg | 26 |
Per Wold-Olsen | 25 |
Severin Schwan | 23 |
Stefan Oschmann | 23 |
Olivier Brandicourt | 23 |
Gabriel Jaramillo-Sanint | 22 |
Hans Jörg Reinhardt | 20 |
Norman Mbazima | 16 |
Sophie O'Connor | 15 |
Albert Bourla | 14 |
Paola Ricci | 11 |
Ugo di Francesco | 11 |
- Borsa valori
- Insiders
- David Reddy
- Connessioni Società